• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Digipath Completes Acquisition of VSSL Enterprises Ltd.

Share:

March 23, 2020

Digipath, Inc. (OTCQB: DIGP) (“DIGP” or the “Company”), a leading independent analytical testing laboratory, data analytics and technology firm focused on the cannabis and hemp markets, is pleased to announce the closing of its acquisition of VSSL Enterprises Ltd. (“VSSL”). VSSL, located in Kelowna, B.C., is a provider of agritech consulting solutions in the areas of cannabis genetics, tissue culture, cultivation, analytical testing and predictive tools.

The two co-founders of VSSL, Kyle Remenda and Dr. Philippe Henry, joined Digipath’s executive team in September 2019, and bring a wealth of scientific and practical expertise and industry relationships to the Company. VSSL and Digipath have previously collaborated on the development of the patent-pending, True Hemp ID mobile genetic testing assay that allows for the genetic distinction between Hemp and Cannabis. It was this collaboration that led the two companies to come together.

Digipath believes that the acquisition of VSSL will provide increased growth for its leading ISO certified analytical lab in Las Vegas, NV due to the relationships and scientific credibility of VSSL’s founders. The acquisition also expands the Company’s global ability to provide customers with technical services in the areas of germplasm development, tissue culture and cultivation. In addition, VSSL will continue to pursue growth opportunities in Canada, where cannabis is federally legal.

“We are excited to bring our vision, expertise, and IP to Digipath and its world class analytical lab,” stated Kyle Remenda, CEO, Digipath, Inc. “Together, I believe we can build a significant company that will be at the vanguard of science-based improvements in the quality and productivity of the global hemp and cannabis industry.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • AliveCor Acquires Cardiolabs and Sets the Stage for the Launch of Advanced Ambulatory Monitoring ServicesAliveCor Acquires Cardiolabs and Sets the Stage for the Launch of Advanced Ambulatory Monitoring Services
  • Medtronic Launches World’s First and Only Infusion Set for Insulin PumpsMedtronic Launches World’s First and Only Infusion Set for Insulin Pumps
  • Leaked IOS14 Code Suggests SP02, Sleep Tracking Features are on Deck for Apple WatchLeaked IOS14 Code Suggests SP02, Sleep Tracking Features are on Deck for Apple Watch
  • Patient Engagement, Management Platform Wellframe Raises $20m in Series C RoundPatient Engagement, Management Platform Wellframe Raises $20m in Series C Round
  • Cleveland Clinic Makes COVID-19 Risk Prediction Model Available Through EpicCleveland Clinic Makes COVID-19 Risk Prediction Model Available Through Epic
  • Flow Raises $1.5m, Healthy.io Makes UTI Test Kits Available in UK Boots Pharmacies, and More News BriefsFlow Raises $1.5m, Healthy.io Makes UTI Test Kits Available in UK Boots Pharmacies, and More News Briefs
  • Sanofi Pushes Further Into Immuno-Oncology with $2.5 Billion Synthorx TakeoverSanofi Pushes Further Into Immuno-Oncology with $2.5 Billion Synthorx Takeover
  • Can AI Pave the Path to Reducing Physician Burnout?Can AI Pave the Path to Reducing Physician Burnout?

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications